Showing results (1391-1400 of 1,415) with videos related to

Sort By:
Pageof 142
Cancer Research|July 30, 2011
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting GenesTimothy R Rebbeck, Nandita Mitra, Susan M Domchek, et al.
Journal of General Internal Medicine|March 23, 2023
Prevalence and Causes of Diagnostic Errors in Hospitalized Patients Under Investigation for COVID-19Andrew D Auerbach, Gopi J Astik, Kevin J O'Leary, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 23, 2023
Global rural health disparities in Alzheimer's disease and related dementias: State of the scienceLisa Ann Kirk Wiese, Allison Gibson, Marc Aaron Guest, et al.
BMC Health Services Research|October 25, 2024
Building common understanding: seeking consensus and defining social prescribing across contexts - a collective commentary on a Delphi studyCaitlin Muhl, Kate Mulligan, Bogdan Chiva Giurca, et al.
Human Molecular Genetics|September 6, 2011
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriersDavid G Cox, Jacques Simard, Daniel Sinnett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Pageof 142